[1]孟庆斌,刘 朝,魏 森,等.症状性优势侧椎动脉非急性期闭塞介入开通的疗效和安全性分析[J].介入放射学杂志,2021,30(05):432-437.
 MENG Qingbin,LIU Chao,WEI Sen,et al.Interventional recanalization of symptomatic non-acute phase occlusion of dominant-side vertebral artery: an analysis of curative effect and safety[J].journal interventional radiology,2021,30(05):432-437.
点击复制

症状性优势侧椎动脉非急性期闭塞介入开通的疗效和安全性分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年05
页码:
432-437
栏目:
神经介入
出版日期:
2021-05-25

文章信息/Info

Title:
Interventional recanalization of symptomatic non-acute phase occlusion of dominant-side vertebral artery: an analysis of curative effect and safety
作者:
孟庆斌 刘 朝 魏 森 管 生
Author(s):
MENG Qingbin LIU Chao WEI Sen GUAN Sheng.
Department of Neurointervention, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450052, China
关键词:
【关键词】 优势侧椎动脉 非急性期 闭塞 介入再通
文献标志码:
A
摘要:
【摘要】 目的 探讨介入开通治疗症状性优势侧椎动脉非急性期闭塞的疗效和安全性。 方法 回顾性分析2017年9月至2019年3月经郑州大学第一附属医院介入治疗的14例症状性优势侧椎动脉非急性期闭塞患者临床资料。采用美国国立卫生研究院卒中量表(NIHSS)评分和改良Rankin 量表(mRS)评分评价治疗前后、随访期患者神经功能和残疾改善情况,同时观察围术期和随访期并发症和预后。结果 介入开通椎动脉闭塞11例,开通成功率为78.6%(11/14)。中位随访145(92~198) d,术后、随访期NIHSS评分,随访期mRS评分均降低,与术前相比差异均有统计学意义(P<0.05)。围术期和随访期并发症少,无死亡及术后再狭窄发生。结论 介入开通治疗症状性优势侧椎动脉非急性期闭塞患者手术成功率较高,术后和随访期患者症状可予改善,但尚需大样本随机对照双盲研究证据支持。

参考文献/References:

[1] Jeng JS, Yip PK. Evaluation of vertebral artery hypoplasia and asymmetry by color-coded duplex ultrasonography[J]. Ultrasound Med Biol, 2004, 30: 605-609.
[2] Zhou M, Zheng H, Gong S, et al. Vertebral artery hypoplasia and vertebral artery dissection: a hospital-based cohort study[J]. Neurology, 2015, 84: 818-824.
[3] Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2018, 49: e46-e110.
[4] Caplan LR. Occlusion of the vertebral or basilar artery. Follow up analysis of some patients with benign outcome[J]. Stroke, 1979, 10: 277-282.
[5] Lindsberg PJ,Soinne L,Roine RO,et al. Options for recana-lization therapy in basilar artery occlusion[J]. Stroke, 2005, 36: 203-204.
[6] Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra- arterial and intravenous thrombolysis[J]. Stroke, 2006, 37: 922-928.
[7] Amin- Hanjani S, Rose- Finnell L,Richardson D,et al. Vertebro- basilar flow evaluation and risk of transient ischaemic attack and stroke study(VERiTAS): rationale and design[J]. Int J Stroke, 2010, 5: 499-505.
[8] Amin- Hanjani S, Du X, Rose- Finnell L,et al. Hemodynamic features of symptomatic vertebrobasilar disease[J]. Stroke, 2015, 46: 1850-1856.
[9] Caplan LR. The intracranial vertebral artery: a neglected species. The Johann Jacob Wepfer Award 2012[J]. Cerebrovasc Dis, 2012, 34: 20-30.
[10] Gaigalaite V, Vilimas A, Ozeraitiene V, et al. Association between vertebral artery hypoplasia and posterior circulation stroke[J]. BMC Neurol, 2016, 16: 118.
[11] Hong JM, Chung CS, Bang OY, et al. Vertebral artery dominance contributes to basilar artery curvature and peri- vertebrobasilar junctional infarcts[J]. J Neurol Neurosurg Psychiatry, 2009, 80: 1087-1092.
[12] Hui FK, Zhu X, Jones SE, et al. Early experience in high-resolution MRI for large vessel occlusions[J]. J Neurointerv Surg, 2015, 7: 509-516.
[13] Al-Smadi AS, Abdalla RN, Elmokadem AH, et al. Diagnostic accuracy of high-resolution black-blood MRI in the evaluation of intracranial large-vessel arterial occlusions[J]. AJNR Am J Neuroradiol, 2019, 40: 954-959.
[14] Gao P, Wang Y, Ma Y, et al. Endovascular recanalization for chronic symptomatic intracranial vertebral artery total occlusion: experience of a single center and review of literature[J]. J Neuroradiol, 2018, 45: 295-304.
[15] He X, Zhang L, Yang J, et al. Multimodal therapy for non-superacute vertebral basilar artery occlusion[J]. Interv Neurol, 2017, 6: 254-262.
[16] Gao P, Wang Y, Ma Y, et al. Endovascular recanalization for chronic symptomatic intracranial vertebral artery total occlusion: experience of a single center and review of literature[J]. J Neu-roradiol, 2018, 45: 295-304.
[17] 陈康宁,王伊龙. 2018症状性动脉粥样硬化性非急性颅内大动脉闭塞血管内治疗中国专家共识[J]. 中国卒中杂志, 2018,13:1166-1181.
[18] 刘 恋,徐晓彤,马 宁,等. 症状性颅内椎-基底动脉闭塞的侧支代偿及介入开通治疗[J]. 中华神经外科杂志, 2017, 33:334-338.
[19] Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis(CICAS) Study[J]. Stroke, 2014, 45: 663-669.
[20] Weimar C, Goertler M, Harms L, et al. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia[J]. Arch Neurol, 2006, 63: 1287-1291.
[21] 贺迎坤,李钊硕,李天晓,等. 非急性期颅内椎-基底动脉闭塞支架再通术围手术期并发症分析[J]. 介入放射学杂志, 2012, 21:797-801.
[22] 李元辉,庞红立,严 澎,等. 症状性非急性期椎基底动脉闭塞介入再通初步探讨[J]. 介入放射学杂志, 2020, 29:493- 497.

相似文献/References:

[1]贺迎坤,王子亮,李天晓,等. 非急性期基底动脉闭塞的腔内再通治疗[J].介入放射学杂志,2014,(01):5.
 HE Ying? kun,WANG Zi? liang,LI Tian? xiao,et al. Endovascular revascularization for non?蛳 acute basilar artery occlusion[J].journal interventional radiology,2014,(05):5.

备注/Memo

备注/Memo:
(收稿日期:2020-10-12)
(本文编辑:边 佶)
更新日期/Last Update: 2021-05-20